Continue reading FDA Menthol Report Good News for Lorillard

FDA Menthol Report Good News for Lorillard originally appeared on BloggingStocks on Fri, 18 Mar 2011 14:00:00 EST. Please see our terms for use of feeds.

If you are looking for clues to tell you which stocks have a good chance of increasing in value, you might want consider watching what insiders are doing. After all, talk is cheap, but when insiders put their own money on the line, you should sit up and take note.

Mattson Technology (MTSN) topped the insider-buying charts for the week ending Feb. 25 as insiders snapped up 5,000,000 shares of company stock at a market value of $12,350,000. During the past six months, insiders have increased their overall holdings in the company by -6.49% and now own 0.14% of MTSN stock.

Continue reading Insiders Snapping Up Mattson Technology, Acelrx Pharmaceuticals and More

Insiders Snapping Up Mattson Technology, Acelrx Pharmaceuticals and More originally appeared on BloggingStocks on Mon, 28 Feb 2011 09:00:00 EST. Please see our terms for use of feeds.

Lorillard (LO - option chain) shares are rising today after the company reported Q4 2010 earnings this morning, posting a profit of $259 million, or $1.74 per share, on revenue of $1.49 billion. Analysts had forecast a profit of $1.67 per share. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on LO.

LO opened this morning at $76.79. So far today the stock has hit a low of $76.01 and a high of $77.20. As of 12:05, LO is trading at $76.55 up $1.55 (2.1%). The chart for LO looks bullish and S&P gives LO a positive 4 STARS (out of 5) buy ranking.

Continue reading Lorillard Boosted by Q4 Earnings

Lorillard Boosted by Q4 Earnings originally appeared on BloggingStocks on Mon, 07 Feb 2011 14:10:00 EST. Please see our terms for use of feeds.

"Readers should be aware of my strong feelings about the health hazards of smoking; investors must make their own decision about investing in tobacco companies," says Jack Adamo.

The editor of Insiders Plus explains, "Despite the moral issues, I'm recommending purchase of cigarette maker, Lorillard (LO).

Continue reading Lorillard (LO): 'Morals Aside, This Tobacco Stock Is a Buy'

Lorillard (LO): 'Morals Aside, This Tobacco Stock Is a Buy' originally appeared on BloggingStocks on Wed, 26 Jan 2011 13:00:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Verizon (VZ) to conviction buy from buy at Goldman.
• CSX (CSX) to outperform from market perform at Wells Fargo.
• AK Steel (AKS) to overweight from neutral, as well as Lorillard (LO) and Fifth Third Bancorp (FITB) to neutral from underweight, at JPMorgan.
• Marathon Oil (MRO) to overweight from equal weight at Morgan Stanley.
• Corning (GLW) to buy from outperform at CLSA.
• Quest Diagnostics (DGX) to buy from hold at Jefferies and to outperform from sector perform at RBC Capital.
• Salesforce.com (CRM) to buy from neutral at Roth Capital.
• Baker Hughes (BHI) to buy from hold at Weeden and to outperform from neutral at Macquarie.
• Western Digital (WDC) and Seagate (STX) to buy from underperform at BofA/Merrill.

Continue reading Analyst Calls: AKS, CIEN, CRM, CSX, DGX, GLW, LO, MRO, OXY, STX, VZ ...

Analyst Calls: AKS, CIEN, CRM, CSX, DGX, GLW, LO, MRO, OXY, STX, VZ ... originally appeared on BloggingStocks on Wed, 26 Jan 2011 12:30:00 EST. Please see our terms for use of feeds.

One of our three value portfolios in the Buyback Letter is the Buyback Income Index, a 10-stock portfolio for those interested in income and growth. It features companies actively repurchasing their own stock that also pay relatively high dividends.

While our main emphasis is on buyback stocks, those stocks that both buy back AND pay a substantial and regular dividend are comforting to some investors who want to know that no matter what, at least they will be getting something back.

Continue reading David Fried's Buyback Income Index Portfolio

David Fried's Buyback Income Index Portfolio originally appeared on BloggingStocks on Thu, 02 Dec 2010 14:40:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Goldman upgraded Eaton (ETN) to conviction buy from neutral.
• AECOM Technology (ACM) was upgraded to outperform from neutral at Macquarie.
• Piper Jaffray upgraded Hologic (HOLX), Gen-Probe (GPRO) and Qiagen (QGEN) to overweight from neutral.
• GeoMet (GMET) was upgraded to accumulate from neutral at Global Hunter.
• Accretive Health (AH) was upgraded to outperform from neutral at RW Baird.
• Morgan Stanley upgraded Reinsurance Group (RGA) to overweight from equal weight.
• BofA/Merrill upgraded Clearwire (CLWR) to neutral from underperform.

Continue reading Analyst Calls: BA, BBBY, CI, CLWR, DFS, DLTR, ETN, MET, MO, WSM ...

Analyst Calls: BA, BBBY, CI, CLWR, DFS, DLTR, ETN, MET, MO, WSM ... originally appeared on BloggingStocks on Fri, 12 Nov 2010 11:30:00 EST. Please see our terms for use of feeds.

Continue reading Lorillard Third-Quarter Earnings Increase

Lorillard Third-Quarter Earnings Increase originally appeared on BloggingStocks on Mon, 25 Oct 2010 10:40:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Piper Jaffray upgraded Edwards Lifesciences (EW) to overweight from neutral and raised its target price for shares to $77 from $53 after The New England Journal of Medicine reported the company's PARTNER Trial met primary endpoints.
• UBS upgraded Endo Pharmaceuticals (ENDP) to buy from neutral and raised its price target to $36 from $25. UBS is positive on Endo's creative strategic deals and believes the switch to Opana TRF from Opana ER will be easy. Additionally, the analyst believes pipeline expectations are very low.
• BMO Capital upgraded Nvidia (NVDA) to outperform from market perform based on expectations that share loss in the core GPU business will stop, Tegra momentum and valuation. The firm raised its price target to $16 from $9.
• FirstEnergy (FE) and Allegheny Energy (AYE) were upgraded to outperform from neutral at Credit Suisse.
• Mylan (MYL) was upgraded to conviction buy from buy at Goldman. Warner
• Chilcott (WCRX) was upgraded to overweight from equal weight at Morgan Stanley.

Continue reading Analyst Calls: CALM, CWT, DD, DYN, ENDP, EW, MO, MOS, NVDA, OXPS, PPL ...

Analyst Calls: CALM, CWT, DD, DYN, ENDP, EW, MO, MOS, NVDA, OXPS, PPL ... originally appeared on BloggingStocks on Thu, 23 Sep 2010 11:50:00 EST. Please see our terms for use of feeds.

Continue reading Rising Cigarette Taxes Can't Keep Lorillard Down

Rising Cigarette Taxes Can't Keep Lorillard Down originally appeared on BloggingStocks on Mon, 12 Jul 2010 17:30:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Janney Montgomery upgraded Microsoft (MSFT) to buy from neutral with a $30 price target, citing valuation and expectations for strong Q4 results.
• UBS upgraded SanDisk (SNDK) to buy from neutral based on favorable pricing and mobile design win momentum. The firm raised its target to $55 from $46.
• BMO Capital upgraded Medtronic (MDT) to outperform from market perform based on valuation and its product pipeline. The firm has a $48 price target on the stock.
• Lorillard (LO) and Qualcomm (QCOM) were upgraded to conviction buy from buy at Goldman.
• Monsanto (MON) was upgraded to buy from hold at Citigroup.
• FedEx (FDX) was upgraded to buy from hold at BB&T.

Continue reading Analyst Calls: AET, FDX, MAR, MDT, MON, MSFT, NOC, QCOM, SNDK, TSL ...

Analyst Calls: AET, FDX, MAR, MDT, MON, MSFT, NOC, QCOM, SNDK, TSL ... originally appeared on BloggingStocks on Mon, 12 Jul 2010 11:20:00 EST. Please see our terms for use of feeds.

Continue reading Three Dividend Duds to Sell Now

Three Dividend Duds to Sell Now originally appeared on BloggingStocks on Mon, 28 Jun 2010 16:40:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Deutsche Bank upgraded U.S. Steel (X) to buy from hold after raising its steel forecasts and upped its target price on shares to $77 from $44. Note, the firm also downgraded AK Steel.
• Credit Suisse upgraded Philip Morris (PM) to outperform from neutral based on a better international outlook.
• JPMorgan upgraded ev3 Inc. (EVVV) to overweight from neutral. The firm sees upside potential to ev3's consensus estimates for 2010 and raised its target price on shares to $19 from $15.
• Vale (VALE) was upgraded to overweight from equal weight at Barclays.
• Xilinx (XLNX) was raised to outperform from sector perform at RBC Capital.
• Shuffle Master (SHFL) was upgraded at KeyBanc to buy from hold.

Continue reading Analyst Upgrades, Downgrades and Initiations: AKS, EVVV, PEB, PM, PWR, S, X ...

Analyst Upgrades, Downgrades and Initiations: AKS, EVVV, PEB, PM, PWR, S, X ... originally appeared on BloggingStocks on Tue, 19 Jan 2010 11:20:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Kaufman Bros. upgraded American Superconductor (NASDAQ: AMSC) to Buy from Hold as it believes the follow-on contract from Sinovel has positive implications. The firm has a $36 price target on shares.
• Goldman upgraded Nike (NYSE: NKE) to Buy from Neutral citing valuation, visible long-term growth, and signs of sales stabilization. The firm has a $75 target on shares.
• Deutsche Bank upgraded Huntington Bancshares (NASDAQ: HBAN) to Buy from Hold on valuation following the recent underperformance. The firm raised its target on shares to $5.50 from $4.
• Novartis (NYSE: NVS) was upgraded to Buy from Hold at Citigroup.
• eHealth (NASDAQ: EHTH) was upgraded to Buy from Accumulate at ThinkEquity.
• China Precision Steel (NASDAQ: CPSL) was upgraded to Hold from Sell at Roth Capital.

Continue reading Analyst upgrades, downgrades and initiations: CBRL, GAME, LO, NKE, RAIL, TGT, WMT ...

Analyst upgrades, downgrades and initiations: CBRL, GAME, LO, NKE, RAIL, TGT, WMT ... originally appeared on BloggingStocks on Wed, 30 Sep 2009 12:00:00 EST. Please see our terms for use of feeds.

As of Tuesday, you'll have to cross a border to buy a clove. The U.S. Food and Drug Administration's ban on flavored cigarettes went into effect and prohibits the sale of candy and fruit-flavored cigarettes. Authorized under the Family Smoking Prevention and Tobacco Control Act, the measure is intended to reduce the number of children who take up the habit.

Under the new ban, cigarettes that include "an artificial or natural flavor (other than menthol) or an herb or spice" cannot be sold in the United States. The long, but not exhaustive list of flavors, consists of strawberry, grape, orange, clove, cinnamon, pineapple, vanilla, coconut, licorice, cocoa, chocolate, cherry and coffee.

Continue reading Flavored cigarettes off the shelves

Flavored cigarettes off the shelves originally appeared on BloggingStocks on Wed, 23 Sep 2009 11:00:00 EST. Please see our terms for use of feeds.

Continue reading Chasing Value: 2008 picks -- the last nail

Chasing Value: 2008 picks -- the last nail originally appeared on BloggingStocks on Mon, 12 Jan 2009 15:00:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY: PetSmart, Banco de Chile and Xerium Technologies were today's noteworthy upgrades:

• JP Morgan upgraded PetSmart (NASDAQ: PETM) to Overweight from Neutral citing the company's position in a relatively strong category, benefits from food inflation, and margin improvements.
  
• Deutsche Bank upgraded shares of Banco de Chile (NYSE: BCH) to Buy from Hold as they expect greater earnings power following the acquisition of Citibank Chile.
  
• Citigroup upgraded Xerium Tech (NYSE: XRM) to Buy from Hold on the success of the company's debt renegotiation. The firm also raised the company's target to $7 from $2.

OTHER UPGRADES:

• Goldman Sachs added State Street (NYSE: STT) and Lorillard (NYSE: LO) to the Conviction Buy List.
  
• Boyd Gaming (NYSE: BYD) was raised to Neutral from Sell at Banc of America.
  
• William Blair raised American Superconductor (NASDAQ: AMSC) to Outperform from Market Perform.
  
• Cameco (NYSE: CCJ) was upgraded to Buy from Neutral at UBS.

Analyst upgrades: PetSmart, Banco de Chile, Xerium Technologies originally appeared on BloggingStocks on Wed, 11 Jun 2008 12:30:00 EST. Please see our terms for use of feeds.

The transaction will close as of trading on Tuesday, June 10. Lorillard is being distributed to the public via a two-tier process involving: 1) the retirement of the tracking stock Carolina Group (NYSE: CG), in exchange for which approximately 62% of Lorillard's common stock will be issued, and 2) an offer in which shares of S&P 500 constituent Loews Corp. can be exchanged for the remaining shares of Lorillard

It was a smart move by Loews company management to separate the tobacco company from its other interests in hospitality, oil exploration, real estate and insurance.

Continue reading Chasing Value: Lorillard Inc. joins the S&P 500

Chasing Value: Lorillard Inc. joins the S&P 500 originally appeared on BloggingStocks on Wed, 04 Jun 2008 15:33:00 EST. Please see our terms for use of feeds.